| 10-Q | 2020-03-31 | Filed 2020-05-12 |
| 10-K | 2019-12-31 | Filed 2020-03-13 |
| 10-Q | 2019-09-30 | Filed 2019-11-04 |
| 10-Q | 2019-06-30 | Filed 2019-08-05 |
| 10-Q | 2019-03-31 | Filed 2019-05-06 |
| 10-K | 2018-12-31 | Filed 2019-03-13 |
| 10-Q | 2018-09-30 | Filed 2018-11-06 |
| 10-Q | 2018-06-30 | Filed 2018-08-07 |
| 10-Q | 2018-03-31 | Filed 2018-05-09 |
| 10-K | 2017-12-31 | Filed 2018-03-13 |
| 8-K | 2018-01-19 |
| Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stemcell Holdings (STMM) | 113% | -1.0 | 26% | 12 | 6 | 7 | 8 | 3 | 5 | -5 | |
| FCCC (FCCC) | 1.5 | -61% | 0 | 0 | 0 | 0 | -0 | -0 | -0 | ||
| Tapinator (TAPM) | 0% | 0.1 | -99% | 2 | 1 | 4 | 0 | -2 | -2 | -0 | |
| Nogales Resources (NLRT) | 0% | 0 | 0 | 0 | 0 | 0 | 0 | -0 | |||
| Golden Growers Cooperative (GGRO) | -0% | 0% | 27 | 2 | 42 | -0 | 0 | 0 | -4 | ||
| Northern Power Systems (NPS) | 22% | 0.4 | -27% | 9 | 14 | 18 | 4 | -2 | -2 | -1 | |
| Twin River Worldwide (TRWH) | 0% | 4.0 | 4% | 1,071 | 808 | 393 | 0 | 42 | 112 | 450 | |
| Bio-En (BENH) | 0.1 | -643% | 0 | 0 | 0 | 0 | -0 | -0 | -0 | ||
| Southwest Iowa Renewable Energy (SIRE) | -1% | -47.3 | -1% | 141 | 52 | 217 | -2 | -1 | -1 | 25 | |
| Texas Republic Capital (TRCC) | 0% | 8.9 | -5% | 26 | 15 | 1 | 0 | -1 | -1 | -11 | |
| Fannie Mae (FNM) | 28.1 | 0% | 3,494,436 | 3,484,094 | 0 | 0 | 13,025 | 119,732 | 3,361,548 | ||
| CBA Florida (CBAI) | 43.6 | -1% | 15 | 1 | 0 | 0 | -0 | -0 | -11 | ||
| Pacific Gold & Royalty (PCFG) | -7.1 | 0 | 4 | 0 | -0 | -0 | -0 | 0 | |||
| BoxScore Brands (BOXS) | 33% | -8.3 | -540% | 0 | 8 | 0 | 0 | -2 | -1 | 6 | |
| Quest Management (QUEST) | 27% | -0.3 | 129% | 0 | 0 | 0 | 0 | 0 | 0 | -0 | |
| Zhen Ding Resources (RBTK) | 0.1 | 48,309,900% | 0 | 0 | -0 | -0 | -0 | ||||
| Hines Global REIT (HGRI) | 0% | 1.7 | 19% | 2,011 | 1,000 | 205 | 0 | 388 | 422 | 716 | |
| Wadena (WDN) | 0% | 0.0 | -2,344% | 0 | 1 | 0 | 0 | -0 | -0 | -0 | |
| Galera Therapeutics (GRTX) | 1.3 | -17% | 80 | 52 | 0 | 0 | -13 | -12 | -16 | ||
| Chase General (CSGN) | 26% | -0.5 | -2% | 2 | 1 | 2 | 1 | -0 | 0 | -0 |
| Balance Sheet ($MM) | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash | 947 | 1,239 | 1,418 | 1,207 | 1,848 | 1,320 | 2,731 | 2,238 |
| Accounts Receivable | ||||||||
| Inventory | ||||||||
| PP&E | ||||||||
| Assets | 281,872 | 279,134 | 299,785 | 304,955 | 299,145 | 314,927 | 323,196 | 326,285 |
| Accounts Payable | ||||||||
| Long-Term Debt | 2,374 | 2,401 | ||||||
| Liabilities | 263,427 | 261,897 | 282,611 | 288,004 | 282,826 | 296,677 | 303,052 | 304,509 |
| Stockholders' Equity | 18,445 | 17,237 | 17,174 | 16,951 | 16,319 | 18,250 | 20,144 | 21,776 |
| Income Statement ($MM) | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Revenue | 3,413 | 3,404 | 3,852 | 4,039 | 4,063 | 3,764 | 3,928 | 4,227 |
| Cost of Revenue | ||||||||
| Gross Profit | ||||||||
| R&D | ||||||||
| SG&A | ||||||||
| Tax | 76 | 75 | 42 | -15 | 20 | -98 | ||
| Net Income | 963 | 407 | 420 | 378 | 368 | 133 | 222 | -201 |
| Cash Flow ($MM) | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
| Cash Operating | 370 | 443 | 331 | -1,637 | -1,677 | -378 | ||
| Cash Investing | -677 | -1,766 | -1,935 | -1,043 | 1,161 | -1,843 | ||
| Cash Financing | 599 | 1,502 | 1,393 | 2,152 | 1,927 | 1,728 | ||